1 / 4

BWH Critical Pathway Feb. 2002: UA/NSTEMI

BWH Critical Pathway Feb. 2002: UA/NSTEMI. Cannon CP Crit Path Cardio 2002;1:12-21. Aspirin, Clopidogrel, Enoxaparin Beta-blocker, Nitrates. Low-Risk – ECG, – Markers TIMI Risk Score < 3. High-Risk ST ’s, +Troponin/CK-MB, or TIMI Risk Score >3. No Cath Planned. Cath Planned.

fola
Download Presentation

BWH Critical Pathway Feb. 2002: UA/NSTEMI

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. BWH Critical Pathway Feb. 2002: UA/NSTEMI Cannon CP Crit Path Cardio 2002;1:12-21. Aspirin, Clopidogrel, Enoxaparin Beta-blocker, Nitrates Low-Risk– ECG, – MarkersTIMI Risk Score <3 High-RiskST ’s, +Troponin/CK-MB, or TIMI Risk Score >3 No Cath Planned Cath Planned GP IIb/IIIa inhibitor ETT Cath/PCI(on GP IIb/IIIa ) Cath GP IIb/IIIa for PCI D/C Day 1 or 2 D/C Day 2 D/C Day 2

  2. Benefit of IIb/IIIa inhibitors in UA/NSTEMI by Troponin PRISM CAPTURE P<0.001 P<0.001 TnT 0.1 TnT >0.1 TnI>0.1 g/L TnI 0.1 g/L Heeschen, Lancet. 1999;354:1757-62 Hamm CW, NEJM 1999;340:1623-9.

  3. BWH ED Critical Pathway Feb. 2002: UA/NSTEMI Cannon CP. Crit Path Cardio 2002;1:12-21.

  4. BWH ED Critical Pathway Feb. 2002: UA/NSTEMI Cannon CP. Crit Path Cardio 2002;1:12-21.

More Related